Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.57M Buy
+150,000
New +$2.78M ﹤0.01% 2202
2025
Q4
Sell
-200,000
Closed -$4.68M 5764
2025
Q3
$4.68M Buy
+200,000
New +$4.01M ﹤0.01% 2255
2024
Q4
Sell
-100,000
Closed -$1.22M 5516
2024
Q3
$1.22M Buy
+100,000
New +$829K ﹤0.01% 3231
2024
Q1
Sell
-65,000
Closed -$948K 5415
2023
Q4
$948K Buy
+65,000
New +$1.03M ﹤0.01% 3469
2023
Q2
Sell
-241,600
Closed -$2.68M 5145
2023
Q1
$2.68M Sell
241,600
-479,800
-67% -$4.64M ﹤0.01% 1969
2022
Q4
$7.17M Buy
+721,400
New +$6.5M ﹤0.01% 1391

Other funds holding XPEV

Barclays's XPEV Position: Q1 2026 in Review

Barclays reduced its XPeng (XPEV) stake by 71% in Q1 2026, selling an estimated $14M and leaving 308,887 shares worth $5.29M. The position accounts for ﹤0.01% of the portfolio, ranked #1782.

Barclays first reported a position in XPEV in Q1 2022 and has held it in 17 quarters since. The position peaked at $30.6M in Q1 2022. 233 funds tracked by Wall St. Rank hold XPEV as of Q1 2026.

  • Barclays held 308,887 shares of XPeng worth $5.29M as of Q1 2026.
  • Barclays sold 751,982 XPeng shares in Q1 2026, an estimated $14M.
  • XPeng made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1782 holding.
  • Barclays first reported a position in XPeng in Q1 2022 and has held it in 17 quarters since.
  • Barclays's XPeng position peaked at $30.6M in Q1 2022.
  • 233 funds tracked by Wall St. Rank held XPeng as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.